| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
17,440 |
16,612 |
$4.98M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
19,148 |
18,554 |
$3.09M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
8,744 |
8,236 |
$2.61M |
| 80053 |
Comprehensive metabolic panel |
21,558 |
19,739 |
$718K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,677 |
1,602 |
$555K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,026 |
1,943 |
$494K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,275 |
20,180 |
$375K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
8,833 |
8,614 |
$305K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
10,098 |
9,439 |
$289K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
9,131 |
8,311 |
$283K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,554 |
6,077 |
$266K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,795 |
1,702 |
$252K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
248 |
243 |
$182K |
| 71046 |
Radiologic examination, chest; 2 views |
2,824 |
2,746 |
$166K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,784 |
1,623 |
$162K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
9,278 |
6,458 |
$159K |
| 71045 |
Radiologic examination, chest; single view |
3,438 |
3,254 |
$156K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,915 |
5,419 |
$151K |
| 81000 |
|
11,929 |
11,234 |
$144K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
9,014 |
8,130 |
$138K |
| 87631 |
|
1,070 |
1,047 |
$115K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,962 |
4,560 |
$90K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
752 |
731 |
$88K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,879 |
1,812 |
$85K |
| 84484 |
|
3,906 |
3,331 |
$80K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,574 |
3,398 |
$80K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,440 |
2,283 |
$76K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,103 |
1,077 |
$74K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
947 |
881 |
$67K |
| 87088 |
|
9,421 |
8,854 |
$63K |
| 83690 |
|
4,773 |
4,450 |
$55K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,168 |
1,082 |
$49K |
| 81025 |
|
2,147 |
2,091 |
$40K |
| 84703 |
|
2,585 |
2,504 |
$38K |
| 80050 |
General health panel |
144 |
140 |
$36K |
| J3490 |
Unclassified drugs |
2,886 |
1,831 |
$33K |
| 74018 |
|
456 |
444 |
$33K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,895 |
3,609 |
$30K |
| J7050 |
Infusion, normal saline solution, 250 cc |
3,224 |
2,757 |
$28K |
| 94664 |
|
242 |
236 |
$27K |
| 81001 |
|
4,210 |
3,969 |
$24K |
| 76801 |
|
240 |
214 |
$23K |
| 87070 |
|
1,341 |
1,317 |
$23K |
| 87430 |
|
1,351 |
1,332 |
$22K |
| 87077 |
|
1,592 |
1,506 |
$21K |
| 84443 |
Thyroid stimulating hormone (TSH) |
889 |
862 |
$20K |
| 87186 |
|
1,336 |
1,273 |
$20K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
148 |
100 |
$19K |
| 85730 |
|
1,952 |
1,799 |
$19K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
672 |
516 |
$17K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
117 |
114 |
$17K |
| 83880 |
|
867 |
819 |
$16K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,970 |
1,671 |
$16K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,199 |
1,010 |
$13K |
| 85610 |
|
2,569 |
2,322 |
$13K |
| 84702 |
|
591 |
515 |
$12K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
515 |
507 |
$12K |
| 72100 |
|
177 |
173 |
$12K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
43 |
37 |
$12K |
| 73610 |
|
108 |
108 |
$11K |
| 73562 |
|
140 |
134 |
$11K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
67 |
47 |
$10K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
211 |
65 |
$9K |
| 76820 |
|
68 |
48 |
$6K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,128 |
967 |
$6K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
424 |
389 |
$6K |
| 73630 |
|
48 |
48 |
$5K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
319 |
264 |
$5K |
| 83735 |
|
1,100 |
848 |
$5K |
| 85379 |
|
427 |
416 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
83 |
82 |
$4K |
| 83605 |
|
382 |
333 |
$4K |
| 80061 |
Lipid panel |
284 |
275 |
$4K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
78 |
66 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
777 |
735 |
$3K |
| 82962 |
|
2,132 |
1,256 |
$3K |
| 84439 |
|
299 |
294 |
$3K |
| 87807 |
|
223 |
219 |
$3K |
| 86900 |
|
489 |
467 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
93 |
86 |
$3K |
| J2704 |
Injection, propofol, 10 mg |
1,092 |
1,037 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
84 |
78 |
$3K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
80 |
73 |
$3K |
| A9270 |
Non-covered item or service |
1,388 |
1,013 |
$2K |
| 73030 |
|
27 |
25 |
$2K |
| 86901 |
|
489 |
467 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
147 |
141 |
$2K |
| 84100 |
|
610 |
467 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
57 |
52 |
$2K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
138 |
131 |
$1K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
3,038 |
2,816 |
$1K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
46 |
45 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
22 |
16 |
$1K |
| 86140 |
|
140 |
133 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
544 |
509 |
$1K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
386 |
351 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
192 |
188 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
13 |
12 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
377 |
359 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
39 |
37 |
$856.28 |
| 73110 |
|
20 |
16 |
$829.70 |
| 85027 |
|
116 |
110 |
$721.44 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
167 |
136 |
$624.79 |
| 87040 |
|
35 |
29 |
$486.81 |
| 82728 |
|
39 |
38 |
$452.77 |
| 82150 |
|
17 |
15 |
$439.75 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
25 |
12 |
$390.61 |
| 85651 |
|
60 |
55 |
$362.25 |
| S0028 |
Injection, famotidine, 20 mg |
157 |
148 |
$331.66 |
| 0001A |
|
149 |
119 |
$299.60 |
| 83550 |
|
24 |
24 |
$246.37 |
| J0687 |
Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg |
16 |
16 |
$206.99 |
| 86850 |
|
26 |
25 |
$206.38 |
| 96376 |
|
90 |
76 |
$195.35 |
| 83540 |
|
24 |
24 |
$180.11 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
61 |
57 |
$179.84 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
562 |
528 |
$169.18 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
30 |
30 |
$162.96 |
| 0012A |
|
331 |
328 |
$123.48 |
| J2060 |
Injection, lorazepam, 2 mg |
13 |
13 |
$103.39 |
| 82565 |
|
15 |
15 |
$90.58 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
1,445 |
1,115 |
$89.40 |
| 0002A |
|
93 |
71 |
$58.06 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
40 |
39 |
$52.38 |
| 94760 |
|
47 |
26 |
$28.31 |
| 0011A |
|
253 |
253 |
$5.92 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
31 |
27 |
$3.26 |
| 97163 |
|
13 |
13 |
$0.00 |